Table 1 Eligibility criteria at the community- and individual-levels for the AVENIR mortality and resistance Stage I trial in Niger
Trial | Level | Eligibility Criteria |
|---|---|---|
Mortality | Community | • Location in Dosso or Tahoua region • Population between 250 and 2499a • Distance > 5 km from district headquarters town • Not designated as a “quartier” on national census • Accessible and safe for study team • Verbal consent from community leader(s) |
Individual | • Primary residence in a study community • Age 1–59 months • Weight ≥ 3.0 • No known allergy to macrolides • Verbal consent of guardian for study participation | |
Resistance | Community | • Location in Dosso • Accessible and safe for study team • Randomly selected • Not included in MORDOR trials • Verbal consent of community leader(s) |
Individual | • Primary residence in a selected study community • 1–59 months old, 7–12 years old or guardian of child eligible for treatment • Randomly selected from census • Verbal consent from guardian |